The Accutane ruling provides some hope for the Ms. Balderrama and Ms. Carl, as the New Jersey appellate court considers their appeal. Read more
The New Jersey Appellate Division on August 11 overturned a $25 million jury verdict for Plaintiff Andrew McCarrell in his Accutane product liability suit against Hoffmann-LaRoche Inc. The c... Read more
In early March 2014 a jury found drugmaker Hoffman LaRoche must pay more than $1.5 million in damages to a woman who developed a form of inflammatory bowel disease after using the company’s... Read more
On February 27th, the New Jersey Supreme Court released an opinion addressing the effect of the New Jersey Product Liability Act, N.J.S.A. 2A:58C-1 to -11 (“PLA”) on New Jersey’s discovery r... Read more
A Birmingham-area man won a $25.16 million verdict recently against Roche Holding AG, a Swiss drug maker, after proving that the company’s acne medicine led to inflammatory bowel disease. An... Read more
Roche Holding AG, the world’s biggest maker of cancer drugs, has pulled its Accutane acne medicine from the U.S. market. The withdrawal comes after juries awarded at least $33 million in dam... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.